Amyotrophic Lateral Sclerosis Clinical Trials

121 recruiting

Amyotrophic Lateral Sclerosis Trials at a Glance

137 actively recruiting trials for amyotrophic lateral sclerosis are listed on ClinicalTrialsFinder across 6 cities in 34 countries. The largest study group is Not Applicable with 43 trials, with the heaviest enrollment activity in Boston, Jacksonville, and New York. Lead sponsors running amyotrophic lateral sclerosis studies include Istituto Auxologico Italiano, Mayo Clinic, and University of Dublin, Trinity College.

Browse amyotrophic lateral sclerosis trials by phase

Treatments under study

About Amyotrophic Lateral Sclerosis Clinical Trials

Looking for clinical trials for Amyotrophic Lateral Sclerosis? There are currently 121 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Amyotrophic Lateral Sclerosis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Amyotrophic Lateral Sclerosis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 137 trials

Recruiting
Not Applicable

Ultra-high-caloric, Fatty Diet in ALS

Amyotrophic Lateral Sclerosis
University of Ulm392 enrolled23 locationsNCT06280079
Recruiting
Phase 1

A Study to Investigate the Safety and Pharmacodynamics of a Single Intrathecal Injection (IT) of INS1202 in Participants With Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis
Insmed Gene Therapy LLC23 enrolled5 locationsNCT07290062
Recruiting
Phase 1Phase 2

Study is to Assess the Safety and Tolerability of VTx-002 in Participants With ALS

Amyotrophic Lateral Sclerosis
Vector Y Therapeutics12 enrolled11 locationsNCT07287397
Recruiting
Phase 2Phase 3

HEALEY ALS Platform Trial - Master Protocol

Amyotrophic Lateral Sclerosis
Merit E. Cudkowicz, MD1,500 enrolled78 locationsNCT04297683
Recruiting

Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

Amyotrophic Lateral SclerosisFrontotemporal DementiaProgressive Supranuclear Palsy
National Institute of Neurological Disorders and Stroke (NINDS)360 enrolled1 locationNCT03225144
Recruiting

The National Amyotrophic Lateral Sclerosis Registry

Amyotrophic Lateral Sclerosis
Centers for Disease Control and Prevention30,000 enrolled1 locationNCT01772602
Recruiting
Not Applicable

Effects of Probiotics in Amyotrophic Lateral Sclerosis-Frontotemporal Dementia Spectrum Disorder (ALS-FTDSD) Patients

ALS (Amyotrophic Lateral Sclerosis)ALSFTDFrontal Temporal Dementia (FTD)
Centre hospitalier de l'Université de Montréal (CHUM)150 enrolled1 locationNCT06051123
Recruiting
Phase 3

Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS

Amyotrophic Lateral Sclerosis
Prilenia500 enrolled5 locationsNCT07322003
Recruiting

EIM Via the Myolex mScan as an ALS Biomarker

Amyotrophic Lateral Sclerosis
Beth Israel Deaconess Medical Center80 enrolled6 locationsNCT06491732
Recruiting

Invasive Home Ventilation in Denmark

Spinal Cord Injuries (SCI)Neuromuscular Diseases (NMD)MSA - Multiple System Atrophy+5 more
Rigshospitalet, Denmark450 enrolled1 locationNCT07467187
Recruiting
Not Applicable

Longitudinal Assessment of Autonomic and Sensory Nervous System in ALS

Amyotrophic Lateral Sclerosis
Istituti Clinici Scientifici Maugeri SpA100 enrolled2 locationsNCT05747937
Recruiting
Not Applicable

Connect-One: Early Feasibility Study of Connexus® Brain-Computer Interface (BCI)

Amyotrophic Lateral Sclerosis
Paradromics2 enrolled3 locationsNCT07357428
Recruiting
Not Applicable

Modeling Amyotrophic Lateral Sclerosis With Fibroblasts

Amyotrophic Lateral Sclerosis
Assistance Publique - Hôpitaux de Paris110 enrolled1 locationNCT06450691
Recruiting

Comprehensive Analysis Platform To Understand, Remedy and Eliminate ALS

Amyotrophic Lateral SclerosisPrimary Lateral SclerosisProgressive Muscular Atrophy+1 more
University of Alberta150 enrolled4 locationsNCT05204017
Recruiting

A Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) in Participants With Superoxide Dismutase 1 (SOD-1) Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis
Biogen125 enrolled1 locationNCT07259980
Recruiting
Not Applicable

The Swedish BioFINDER 2 Study

DementiaMultiple System AtrophyAlzheimer Disease+10 more
Skane University Hospital2,950 enrolled2 locationsNCT03174938
Recruiting
Phase 2

Dazucorilant in Patients With Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis
Corcept Therapeutics279 enrolled35 locationsNCT05407324
Recruiting

Disease Biosignatures in ALS/FTD Spectrum: New Impactful Biological Perspectives Beyond Clinical Approaches

FTDALS (Amyotrophic Lateral Sclerosis)Frontotemporal Dementia (FTD)+3 more
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta230 enrolled4 locationsNCT06856850
Recruiting

Diagnostic Accuracy of SleepImage Technology for Detecting Respiratory Failure in Patients With Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis
Royal Brompton & Harefield NHS Foundation Trust15 enrolled1 locationNCT07502677
Recruiting

The Pre-symptomatic Familial Amyotrophic Lateral Sclerosis (Pre-fALS) Study

Amyotrophic Lateral Sclerosis
University of Miami500 enrolled1 locationNCT00317616